Article
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
2022-12-07
Abstract excerpt
<title>Abstract</title> <p>Heterozygous mutation targeting proline 95 in Serine/Arginine-rich Splicing Factor 2 (SRSF2), associates with V617F mutation in Janus Activated Kinase 2 (JAK2) in some myeloproliferative neoplasms (MPNs), most commonly primary myelofibrosis. To explore <italic>Srsf2</italic><sup>P95H</sup> interaction with <italic>Jak2</italic><sup>V617F</sup>, we generated Cre-inducible knock-in mice e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 41c6b0cc-4ccd-5d4a-80e4-555de857b3da
- DOI
- 10.21203/rs.3.rs-2338471/v1
